Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 15;13(2):5-16.
eCollection 2022.

Effects of Senegal haplotype (Xmn1-rs7412844), alpha-thalassemia (3.7kb HBA1/HBA2 deletion), NPRL3-rs11248850 and BCL11A-rs4671393 variants on sickle cell nephropathy

El Hadji Malick Ndour  1   2 , Khuthala Mnika  3 , Fatou Guèye Tall  1   2 , Moussa Seck  4 , Indou Dème Ly  2 , Victoria Nembaware  3 , Hélène Ange Thérèse Sagna-Bassène  2 , Rokhaya Dione  2 , Aliou Abdoulaye Ndongo  5 , Jean Pascal Demba Diop  6 , Nènè Oumou Kesso Barry  1 , Moustapha Djité  1 , Rokhaya Ndiaye Diallo  6 , Papa Madièye Guèye  1 , Saliou Diop  4 , Ibrahima Diagne  7 , Aynina Cissé  1 , Ambroise Wonkam  3 , Philomène Lopez Sall  1   2
Affiliations

Effects of Senegal haplotype (Xmn1-rs7412844), alpha-thalassemia (3.7kb HBA1/HBA2 deletion), NPRL3-rs11248850 and BCL11A-rs4671393 variants on sickle cell nephropathy

El Hadji Malick Ndour et al. Int J Biochem Mol Biol. .

Abstract

Objective: Sickle cell anemia (SCA) can cause substantial kidney dysfunction resulting in sickle cell nephropathy, which may be affected by the presence of modifier genes. This study evaluates the effects of some modifier genes on sickle cell nephropathy.

Methods: Patients living with SCA were recruited. Alpha-thalassemia (3.7kb HBA1/HBA2 deletion) was genotyped using gap PCR multiplex. Senegal haplotype (Xmn1-rs7412844), BCL11A-rs4671393 and NPRL3-rs11248850 were genotyped using Mass Array. The effects of variants on kidney dysfunction were then evaluated using multivariate analysis.

Results: The number of patients living with SCA included in this study was 162 with a median age of 20 years [minimum-maximum: 4-57] and a female frequency of 53.21%. Senegal haplotype, BCL11A-rs4671393 variant were protective factors against albuminuria stage A2 with an odds ratio (OR) of 0.22 (95% CI 0.05-0.90) and 0.27 (95% CI 0.08-0.96) respectively. The combination NPRL3-rs11248850 variant - 3.7kb HBA1/HBA2 deletion was a protective factor against albuminuria stage A2 (OR = 0.087, 95% Cl 0.01-0.78) but it was a risk factor for glomerular hyperfiltration (OR = 17.69, 95% CI 1.85-169.31).

Conclusions: All four variants displayed a protective effect against albuminuria stage A2. The combination alpha-thalassemia - NPRL3-rs11248850 variant is a risk factor for glomerular hyperfiltration.

Keywords: Senegal haplotype; albuminuria; alpha-thalassemia; glomerular filtration rate; kidney dysfunction.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Genotypic frequency of the variants.
Figure 2
Figure 2
Frequency of the combination 3.7 HBA1/HBA2-NPRL3 11248850 (N = 139).
Figure 3
Figure 3
Allelic frequency of the variants.
See this image and copyright information in PMC

References

    1. NCBI-ClinVar. NM_000518.5(HBB):c.20A>T (p.Glu7Val) https://www.ncbi.nlm.nih.gov/clinvar/variation/15333/. Date accessed 2021-10-07.
    1. Saraf SL, Zhang X, Kanias T, Lash JP, Molokie RE, Oza B, Lai C, Rowe JH, Gowhari M, Hassan J. Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. Br J Haematol. 2014;164:729–39. - PMC - PubMed
    1. Guasch A, Cua M, Mitch WE. Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int. 1996;49:786–91. - PubMed
    1. Hatch FE, Culbertson JW, Diggs LW. Nature of the renal concentrating defect in sickle cell disease. J Clin Invest. 1967;46:336–45. - PMC - PubMed
    1. Guasch A, Zayas CF, Eckman JR, Muralidharan K, Zhang W, Elsas LJ. Evidence that microdeletions in the α globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol. 1999;10:1014–9. - PubMed

LinkOut - more resources